News & Updates

Existing scoring systems for magnetic resonance imaging (MRI) scans are sufficiently predictive of cognitive and motor outcomes in term-born infants, a recent study has found. For language assessment, more detailed scoring inventories seem to perform better.

A device for treating aneurysms or balloon-like swelling of blood vessels due to weakened artery walls has passed muster in real world, showing a favourable efficacy and safety profile, according to data from the WorldWideWEB Consortium.

Rivaroxaban was associated with a greater risk of major ischaemic or haemorrhagic events compared with apixaban in elderly patients with atrial fibrillation (AF) — suggesting that apixaban appears to be preferable over rivaroxaban when considering oral anticoagulant choice in these patients, according to a retrospective cohort study.

New drug applications approved by US FDA as of 16-31 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A territory-wide retrospective cohort study by the Chinese University of Hong Kong (CUHK) has found that stroke is the third strongest predictor of coronavirus disease 2019 (COVID-19) mortality, after advancing age and renal disease, while Parkinson’s disease (PD) was the second strongest predictor of death after advancing age during the severe acute respiratory syndrome (SARS) epidemic of 2003.

A longitudinal pilot study by the Chinese University of Hong (CUHK) and Northwestern Polytechnical University in Xi’an, China, used electrical impedance myography (EIM) and surface electromyography (sEMG) to demonstrate that functional electrical stimulation (FES)–assisted cycling training improves lower limb function in chronic stroke survivors through increasing muscle impedance properties, improving muscle activation capacity, and allowing better muscle coordination during ankle joint movements.